Join a live webinar led by Ashkan Emadi, MD, PhD  - Alexander Bland Osborn Endowed Chair and Distinguished Professor of Medical Oncology at West Virginia University School of Medicine and Physician-in-Chief, Medical Oncology, West Virginia University Health System & WVU Medicine Associate Center Director for Translational Research, WVU Cancer Institute along with and Lydia Benitez, PharmD, BCOP - Clinical Assistant Professor, University of Michigan College of Pharmacy (MI) focused on the current practice and identification of barriers to the evidence-based frontline management of ALL in the community setting. The goal is to facilitate peer-to-peer learning/discussion

Complete this 30-minute eCourse to explore the use of genetic testing in clinical settings for prostate cancer care.

ACCC’s Effective Care Coordination Practices Across the CAR T-Cell Therapy Care Continuum e-Course educates the multidisciplinary cancer care team on actionable solutions to improve patient access to CAR T-cell therapy and optimize care continuity between referring programs and CAR T-cell therapy centers.

This live-streaming webinar addresses the challenges of clinical variant interpretation and highlights how the adoption of clinical decision support tools is streamlining precision oncology workflows as well as elucidating complex variants and the hierarchy of data organization.

A captivating live panel discussion to examine the role of pathology in precision medicine and how collaboration and cooperation can help bridge the care coordination gap.

Through this brief self-paced online eCourse, oncology professionals can better address the existing barriers to quality bladder cancer care for underserved populations and improve care coordination for improved health outcomes.

This webinar will provide an overview of the current insurance coverage landscape for CAR T-cell therapy. The discussion will focus on existing financial barriers and challenges that cancer programs face as they help patients and caregivers navigate CAR T-cell therapy.

Providing access to the latest CAR T-cell therapies is a key concern for professionals and patients in the community cancer setting. This webinar will explore what resources are required for establishing CAR T-cell therapy services in the community setting and how cancer programs and practices can prepare and budget for successful implementation.

Biomarker testing is increasingly important for cancer care as it helps tailor specific biomarker-driven therapy for each patient with advanced or metastatic cancers. In this session, we will discuss case studies on how patients can be identified for tailored therapy through biomarker testing and how this testing impacted treatment decisions.

Through multidisciplinary coordination, effective communication, and a robust quality improvement initiative, we'll share invaluable insights, strategies, and patient-centered approaches that redefine ovarian cancer care. Gain firsthand knowledge from our panel of experts as they reveal lessons learned and experiences from participating in this quality improvement initiative. Discover how these insights have informed practice improvements, all while exploring the innovative Ovarian Quality of Care self-assessment tool, a valuable resource for cancer programs to enhance patient outcomes and drive excellence in ovarian cancer care.